SLDB

NASDAQ · Biotechnology

Solid Biosciences Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.19

+0.12 (+1.70%)

As of May 9, 1:47 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +51.6% upside

Low Target $9.47

Average Target $10.90

High Target $14.24

Current Price $7.19

Current
$7.19

Target
$10.90

$9.47 $10.90 avg $14.24

Scenario Analysis

Bear Case

$9.47

31.7%

Low target

Base Case

$10.90

+51.6%

Avg target

Bull Case

$14.24

+98.1%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$8.87

-18.9% from high

52-Week Low

$2.41

+198.3% from low

Target vs 52W High

$10.90

+22.9% vs high

Next Earnings Report

May 13, 2026

until earnings

EPS Est: $-0.44

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%